REST and Parkinson disease: On the other hand, the loss of REST from the nuclei of dopaminergic neurons has been reported in patients with Parkinson's disease; instead the REST immunoreactivity was observed in Lewy bodies, apparently the accumulation of aggregates may prevent neuroprotective signaling through the REST sequestration mechanism [20].